(SeeNews) - Aug 6, 2013 - US Codexis Inc (NASDAQ:CDXS) is engaged in a licence deal breach dispute with US early-stage biotechnology firm Dyadic International Inc (PINK:DYAI) that might relate to its CodeXyme cellulase enzymes for biofuels production.